Nextremity Solutions INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.8Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
119clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Lon Weiner | New York, NY | $273,255.40 | |
| Stuart Katchis | New York, NY | Orthopaedic Surgery | $268,444.63 |
| Martin Omalley | New York, NY | Orthopaedic Surgery | $126,380.43 |
| John Early | Dallas, TX | Foot and Ankle Surgery | $111,186.08 |
| Michael Lee | Des Moines, IA | Foot & Ankle Surgery | $103,629.73 |
| John Anderson | Grand Rapids, MI | Foot and Ankle Surgery | $97,957.22 |
| Jordan Grossman | Akron, OH | Foot & Ankle Surgery | $95,966.46 |
| Donald Bohay | Grand Rapids, MI | Orthopaedic Surgery | $87,143.21 |
| Shannon Rush | Pleasanton, CA | Podiatrist | $71,871.17 |
| Troy Boffeli | Saint Paul, MN | Foot & Ankle Surgery | $68,451.81 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.